Solid phase synthesis of 1,4-benzothiazepin-5-one derivatives

Tetrahedron Letters

Volumn 40, Issue 27, 1999, Pages 4939-4942

  Nefzi, Adel ^a   Ong, Nhi A ^a   Giulianotti, Marc A ^a   Ostresh, John M ^a   Houghten, Richard A ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZOTHIAZEPIN 5 ONE DERIVATIVE; BENZOTHIAZEPINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CYCLIZATION; SOLID PHASE EXTRACTION; SYNTHESIS;

EID: 0033516632     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00964-8     Document Type: Article

References (23)

1. For reviews on solid phase organic synthesis, see: (a) Gallop, M. A.; Barret, R. W.; Dower, W. J; Fodor, S. P. A.; Gordon, E. M. J. Med. Chem. 1994, 37, 1233.
2. (b) Gordon, E. M.; Barret, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. J. Med. Chem. 1994, 37, 1385.
3. (c) Thompson, L.A.; Ellman, J. A. Chem. Rev. 1996, 96, 555.
4. (d) Fruchtel, J. S.; Jung, G. Angew. Chem. Int. Ed Engl. 1996, 35, 17.
5. (e) Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron 1996, 52, 4527.
6. (f) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Chem. Rev. 1997, 97, 449.
7. (a) Merrifield, R. B. J. Am. Chem. Soc. 1963, 85, 2149.
8. (b) Merrifield, R. B. Science 1986, 232, 341.
9. Slade, J.; Stanton, J. L.; Ben-David, D.; Mazzenga, G. C. J. Med Chem. 1985, 28, 1517.
10. Kantoci, D.; Murray, E. D.; Quiggle, D. D.; Wechter, W. J. J. Med Chem. 1996, 39, 1196.
11. Godfraind, T.; Miller, R.; Wibo, M. Pharmacol. Rev. 1986, 38, 21.
12. Gupta, R. R.; Dev, P. K.; Sharma, M. L.; Rajoria, C. M.; Gupta, A.; Nyati, M. Anti-cancer Drugs 1993, 4, 589.
13. (a) Ostresh, J. M.; Schoner, C. C., Hamashin, V. T.; Nefzi, A.; Meyer, J-P.; Houghten, R. A. J. Org. Chem. 1998, 63, 8622.
14. (b) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Tetrahedron 1999, 55, 335.
15. (c) Nefzi, A.; Ostresh, J. M.; Meyer, J-P., Houghten, R. A. Tetrahedron Letters 1997, 38, 93.
16. (d) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Tetrahedron Letters 1997, 38, 4943.
17. (e) Nefzi, A.; Giulianotti, M.; Houghten, R. A. Tetrahedron Letters 1998, 39, 3671.
18. (f) Nefzi, A.,Dooley, C., Ostresh, J. M., Houghten, R. A. Bioorg. Med. Chem. Lett. 1988, 8, 2273.
19. 6): 36.17, 43.44, 59.50, 120.30, 120.88, 122.04, 126.63, 127.00, 127.89, 128.05, 128.35, 129.06, 133.65, 135.74, 138.21, 139.77, 141.74, 168.9, 169.35, 169.38.
20. Houghten, R. A. Proc Nat Acad Sci. USA 1985, 82, 5131.
21. (a) Houghten, R. A.; Pinilla, C.; Blondelle, S. E.; Appel, J. R.; Dooley, C. T.; Cuervo, J. H. Nature 1991, 354, 84.
22. (b) Lam, K. S.; Salmon, S. E.; Hersh, E. M.; Hruby, V. J.; Kazmierski, W. M.; Knapp, R. J. Nature 1991, 354, 82.
23. (c) Furka, A.; Sebastien, F.; Asgedom, M.; Dibo, G., Int. J. Pept. Protein Res. 1991, 37, 487.